Highlights Q-linea AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 11:29:40 2024-05-13 EDT			5-day change	1st Jan Change
2.29 ^SEK	+0.88%		+2.23%	-38.11%

04-26	Q-Linea AB Receives FDA 510(k) Clearance for the ASTar® System	CI
03-13	Q-linea AB Presents Strong ASTar Results At AMCLI	CI

Q-Linea AB Receives FDA 510(k) Clearance for the ASTar® System	04-26	CI
Q-linea AB Presents Strong ASTar Results At AMCLI	03-13	CI
Q-linea AB Reports Earnings Results for the Full Year Ended December 31, 2023	02-27	CI
Q-linea AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-27	CI
Q-linea Presents at AMCLI	02-15	CI
Q-linea to Develop Diagnostic Product Podler Via Separate Subsidiary	02-09	MT
Q-linea Lands First ASTar Order from Finnish Distributor	01-31	MT
Q-Linea AB Receives an Order for an ASTar System	01-31	CI
Q-linea AB Expands the Gram-Negative Panel	01-17	CI
Q-Linea Wins Public Tender for Rapid AST	01-15	CI
Q-linea Installs First ASTar Systems in US; Shares Jump	12-28	MT
Q-linea Signs Distribution Deal for Benelux Region with Biomedical Diagnostics	11-17	MT
Q-linea AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-02	CI
Sweden's Q-linea Partners with Labema to Boost Presence in Finland, Baltic States	23-10-19	MT
Q-Linea AB Strengthens its Presence in Finland and the Baltics Through Partnership with Labema Oy	23-10-19	CI
Q-linea AB Receives Second ASTar Order in France	23-09-28	CI
Q-linea Shares Gain Amid Progress of French Distribution Deal	23-07-27	MT
Q-linea AB Receives First ASTar Order in France	23-07-27	CI
Q-linea AB Completes its 510(k) Application for US Market Approval	23-07-17	CI
Q-linea AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-13	CI

No results for this search